Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

首次发布于 2017 年 1 月 23 日

Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza

计划入组 190 人 · 首次发布于 2024 年 7 月 18 日

To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

计划入组 16 人 · 首次发布于 2024 年 7 月 3 日

Influenza virus type A (H3N2)(FluMist Quadrivalent)

Influenza virus type A (H1N1)(FluMist Quadrivalent)

Influenza virus type B

Research Institute of Influenza

Russia

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Hidden Army of Tissue-Resident Memory T Cells Defends Human Lungs Against a Broad Range of Pathogens

CEPI Partners with Samsung Biologics to Strengthen Global Vaccine Manufacturing for Future Pandemics

Influenza B Triggers Earlier, More Robust Immune Response Than Influenza A, Study Finds